Jarrad Mattieu Aguirre, Chief Medical Officer at Lyell Immunopharma, Inc. (LYEL), sold 422 shares at $8.63 ($4K) on 2026-10-12, disclosed to the SEC on 2026-10-13.
Open-market sale of $4k LYEL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.